Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer

Endocrine-Related Cancer

Volumn 22, Issue 5, 2015, Pages 851-861

  O'Mara, Tracy A ^a   Glubb, Dylan M ^a   Painter, Jodie N ^a   Cheng, Timothy ^b   Dennis, Joe ^c   Attia, John ^d,e   Holliday, Elizabeth G ^d,e   McEvoy, Mark ^e   Scott, Rodney J ^d,f,g,h   Ashton, Katie ^d,g,h   Proietto, Tony ^e   Otton, Geoffrey ^e   Shah, Mitul ⁱ   Ahmed, Shahana ⁱ   Healey, Catherine S ⁱ   Gorman, Maggie ^b   Martin, Lynn ^b   Hodgson, Shirley ^j   Fasching, Peter A ^k,l   Hein, Alexander ^l   Beckmann, Matthias W ^l   Ekici, Arif B ^l   Hall, Per ^m   Czene, Kamila ^m   Darabi, Hatef ^m   Li, Jingmei ^m   Dürst, Matthias ⁿ   Runnebaum, Ingo ⁿ   Hillemanns, Peter ^o   Dörk, Thilo ^o   Lambrechts, Diether ^p,q   Depreeuw, Jeroen ^p,q   Annibali, Daniela ^q   Amant, Frederic ^q   Zhao, Hui ^p,q   Goode, Ellen L ^r   Dowdy, Sean C ^r   Fridley, Brooke L ^s   Winham, Stacey J ^r   Salvesen, Helga B ^t,u   Njølstad, Tormund S ^t,u   Trovik, Jone ^t,u   Werner, Henrica M J ^t,u   Tham, Emma ^m   Liu, Tao ^m   Mints, Miriam ^v   Bolla, Manjeet K ^c   Michailidou, Kyriaki ^c   Tyrer, Jonathan P ⁱ   Wang, Qin ^c   Hopper, John L ^w   Peto, Julian ^x   Swerdlow, Anthony J ^y   Burwinkel, Barbara ^z,aa   Brenner, Hermann ^aa   Meindl, Alfons ^ab   Brauch, Hiltrud ^aa,ac,ad   Lindblom, Annika ^m   Chang Claude, Jenny ^aa   Couch, Fergus J ^r   Giles, Graham G ^w,ae,af   Kristensen, Vessela N ^ag,ah,ai   Cox, Angela ^aj   Pharoah, Paul D P ⁱ   Dunning, Alison M ⁱ   Tomlinson, Ian ^b   Easton, Douglas F ^c,i   Thompson, Deborah J ^c   Spurdle, Amanda B ^a   more..

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d JOHN HUNTER HOSPITAL   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f JOHN HUNTER HOSPITAL   (Australia)

^g UNIVERSITY OF NEWCASTLE   (Australia)

^h UNIVERSITY OF NEWCASTLE   (Australia)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ JENA UNIVERSITY HOSPITAL   (Germany)

^o HANNOVER MEDICAL SCHOOL   (Germany)

^p Vesalius Research Center   (Belgium)

^q UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^r MAYO CLINIC   (United States)

^s UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF BERGEN   (Norway)

^u HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^v KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^w UNIVERSITY OF MELBOURNE   (Australia)

^x LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^y INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^z UNIVERSITY OF HEIDELBERG   (Germany)

^aa GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ab TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ac DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^ad UNIVERSITY OF TÜBINGEN   (Germany)

^ae CANCER EPIDEMIOLOGY CENTRE   (Australia)

^af MONASH UNIVERSITY   (Australia)

^ag OSLO UNIVERSITY HOSPITAL   (Norway)

^ah UNIVERSITY OF OSLO   (Norway)

^ai AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^aj UNIVERSITY OF SHEFFIELD   (United Kingdom)

more..

Author keywords

Endometrial cancer; ESR1; Fine mapping analysis; Single nucleotide polymorphisms

Indexed keywords

ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CANCER; ESR1 GENE; FEMALE; GENE; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENE TARGETING; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PROMOTER REGION; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGY; BREAST TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; ENDOMETRIUM TUMOR; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS (TOPIC); PROGNOSIS; RISK FACTOR;

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; SYNE1 PROTEIN, HUMAN;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; META-ANALYSIS AS TOPIC; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84942112645     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-15-0319     Document Type: Article

References (55)

1. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U & Scott RJ 2009 Estrogen receptor polymorphisms and the risk of endometrial cancer. BJOG: An International Journal of Obstetrics and Gynaecology 116 1053-1061. (doi:10.1111/j.1471-0528.2009. 02185.x)
2. Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U & Scott RJ 2010 Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk. Cancer Epidemiology 34 328-337. (doi:10.1016/j.canep. 2010.03.005)
3. Aulchenko YS, Ripke S, Isaacs A & van Duijn CM 2007 GenABEL: an R library for genome-wide association analysis. Bioinformatics 23 1294-1296. (doi:10.1093/bioinformatics/btm108)
4. Bahcall OG 2013 iCOGS collection provides a collaborative model. Foreword. Nature Genetics 45 343. (doi:10.1038/ng.2592)
5. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ & Altshuler D 2005 Efficiency and power in genetic association studies. Nature Genetics 37 1217-1223. (doi:10.1038/ng1669)
6. CancerGenomeAtlasResearchNetwork,KandothC,SchultzN,CherniackAD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R et al. 2013 Integrated genomic characterization of endometrial carcinoma. Nature 497 67-73. (doi:10.1038/nature12113)
7. Carvajal-Carmona LG, O'Mara TA, Painter JN, Lose FA, Dennis J, Michailidou K, Tyrer JP, Ahmed S, Ferguson K, Healey CS et al. 2015 Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Human Genetics 134 231-245. (doi:10. 1007/s00439-014-1515-4)
8. Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G et al. 2010 ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiology, Biomarkers & Prevention 19 245-250. (doi:10.1158/1055-9965.EPI-09-0729)
9. Dunning AM, Healey CS, Baynes C,Maia AT, Scollen S, Vega A, Rodriguez R, Barbosa-Morais NL, Ponder BA, SEARCH et al. 2009 Association of ESR1 gene tagging SNPs with breast cancer risk. Human Molecular Genetics 18 1131-1139. (doi:10.1093/hmg/ddn429)
10. Einarsdottir K, Darabi H, Li Y, Low YL, Li YQ, Bonnard C, Sjolander A, Czene K,Wedren S, Liu ET et al. 2008 ESR1 and EGF genetic variation in relation to breast cancer risk and survival. Breast Cancer Research 10 R15. (doi:10.1186/bcr1861)
11. Einarsdottir K, Darabi H, Czene K, Li Y, Low YL, Li YQ, Bonnard C,Wedren S, Liu ET, Hall P et al. 2009 Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival. British Journal of Cancer 100 1358-1364. (doi:10.1038/sj.bjc.6604984)
12. Encode Project Consortium, Bernstein BE, Birney E, Dunham I, Green ED, Gunter C & SnyderM2012 An integrated encyclopedia of DNA elements in the human genome. Nature 489 57-74. (doi:10.1038/nature11247)
13. Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE, Oei L, Albagha OM, Amin N, Kemp JP et al. 2012 Genome-wide metaanalysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nature Genetics 44 491-501. (doi:10. 1038/ng.2249)
14. Fan J & Beck KA 2004 A role for the spectrin superfamily member Syne-1 and kinesin II in cytokinesis. Journal of Cell Science 117 619-629. (doi:10.1242/jcs.00892)
15. Ferreira T & Marchini J 2011 Modeling interactions with known risk loci-a Bayesian model averaging approach. Annals of Human Genetics 75 1-9. (doi:10.1111/j.1469-1809.2010.00618.x)
16. Fuchsberger C, Abecasis GR & Hinds DA 2015 minimac2: faster genotype imputation. Bioinformatics 31 782-784. (doi:10.1093/bioinformatics/btu704)
17. Ghoussaini M, Edwards SL, Michailidou K,Nord S,Cowper-Sal Lari R,Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM et al. 2014 Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature Communications 4 4999. (doi:10.1038/ncomms5999)
18. Glubb DM, Maranian MJ, Michailidou K, Pooley KA, Meyer KB, Kar S, Carlebur S, O'Reilly M, Betts JA, Hillman KM et al. 2015 Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. American Journal of Human Genetics 96 5-20. (doi:10.1016/j.ajhg.2014.11.009)
19. Gough LL, Fan J, Chu S, Winnick S & Beck KA 2003 Golgi localization of Syne-1. Molecular Biology of the Cell 14 2410-2424. (doi:10.1091/mbc. E02-07-0446)
20. Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquita HB et al. 2012 Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS ONE 7 e42380. (doi:10.1371/journal.pone. 0042380)
21. Higgins JP & Thompson SG 2002 Quantifying heterogeneity in a metaanalysis. Statistics in Medicine 21 1539-1558. (doi:10.1002/sim.1186)
22. Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA & Young RA 2013 Super-enhancers in the control of cell identity and disease. Cell 155 934-947. (doi:10.1016/j.cell.2013.09.053)
23. Howie BN, Donnelly P & Marchini J 2009 A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genetics 5 e1000529. (doi:10.1371/journal.pgen. 1000529)
24. Howie B, Fuchsberger C, Stephens M, Marchini J & Abecasis GR 2012 Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nature Genetics 44 955-959. (doi:10.1038/ng.2354)
25. Iwamoto I, Fujino T, Douchi T & Nagata Y 2003 Association of estrogen receptor a and b3-adrenergic receptor polymorphisms with endometrial cancer. Obstetrics and Gynecology 102 506-511. (doi:10.1016/S0029-7844(03)0578-7)
26. Kaaks R, Lukanova A & Kurzer MS 2002 Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiology, Biomarkers & Prevention 11 1531-1543.
27. Kanaya T, Kyo S, Maida Y, Yatabe N, Tanaka M, Nakamura M & Inoue M 2003 Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers. Oncogene 22 2352-2360. (doi:10.1038/sj.onc.1206365)
28. Key TJ & Pike MC 1988 The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. British Journal of Cancer 57 205-212. (doi:10.1038/bjc.1988.44)
29. Kheradpour P & KellisM2014 Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments. Nucleic Acids Research 42 2976-2987. (doi:10.1093/nar/gkt1249)
30. Korch C, Spillman MA, Jackson TA, Jacobsen BM, Murphy SK, Lessey BA, Jordan VC & Bradford AP 2012 DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. Gynecologic Oncology 127 241-248. (doi:10.1016/j.ygyno.2012.06.017)
31. Li Y, Willer C, Sanna S & Abecasis G 2009 Genotype imputation. Annual Review of Genomics and Human Genetics 10 387-406. (doi:10.1146/annurev.genom.9.081307.164242)
32. Li Y, Willer CJ, Ding J, Scheet P & Abecasis GR 2010 MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genetic Epidemiology 34 816-834. (doi:10.1002/gepi.20533)
33. Li G, Xiang YB, Courtney R, Cheng JR, Huang B, Long JR, Cai H, Zheng W, Shu XO & Cai Q 2011 Association of a single nucleotide polymorphism at 6q25.1,rs2046210, with endometrial cancer risk among Chinese women. Chinese Journal of Cancer 30 138-143. (doi:10.5732/cjc.010.10516)
34. Li Q, Seo JH, Stranger B, McKenna A, Pe'er I, Laframboise T, Brown M, Tyekucheva S & Freedman ML 2013 Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152 633-641. (doi:10.1016/j.cell.2012.12.034)
35. Loven J,HokeHA, Lin CY, Lau A,OrlandoDA, Vakoc CR, Bradner JE, Lee TI& Young RA 2013 Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153 320-334. (doi:10.1016/j.cell.2013.03.036)
36. Macintyre G, Bailey J, Haviv I & Kowalczyk A 2010 is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics 26 i524-i530. (doi:10.1093/bioinformatics/btq378)
37. Marchini J & Howie B 2010 Genotype imputation for genome-wide association studies. Nature Reviews. Genetics 11 499-511. (doi:10.1038/nrg2796)
38. Marme A, Zimmermann HP, Moldenhauer G, Schorpp-Kistner M, Muller C, Keberlein O, Giersch A, Kretschmer J, Seib B, Spiess E et al. 2008 Loss of Drop1 expression already at early tumor stages in a wide range of human carcinomas. International Journal of Cancer 123 2048-2056. (doi:10.1002/ijc.23763)
39. Painter JN, O'Mara TA, Batra J, Cheng T, Lose FA, Dennis J, Michailidou K, Tyrer JP, Ahmed S, Ferguson K et al. 2014 Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Human Molecular Genetics 24 1478-1492. (doi:10.1093/hmg/ddu552)
40. Perry JR, Day F, ElksCE, SulemP,ThompsonDJ, Ferreira T,HeC,ChasmanDI, Esko T, Thorleifsson G et al. 2014 Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature 514 92-97. (doi:10.1038/nature13545)
41. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N & Dahiya R 2002 Polymorphisms of estrogen receptor a gene in endometrial cancer. Biochemical and Biophysical Research Communications 297 558-564. (doi:10.1016/S0006-291X(02)2248-9)
42. Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, Yi JM, Chan TA, Van Neste L, Van Criekinge W, van den Bosch S et al. 2007 Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genetics 3 1709-1723. (doi:10.1371/journal.pgen. 0030157)
43. Schwarzer G 2010 Meta: Meta-Analysis with R, package 1.6-1. (available at: http://CRAN.R-project.org/package=meta)
44. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N et al. 2006 The consensus coding sequences of human breast and colorectal cancers. Science 314 268-274. (doi:10.1126/science.1133427)
45. Sliwinski T, Sitarek P, Stetkiewicz T, Sobczuk A & Blasiak J 2010 Polymorphism of the ERa and CYP1B1 genes in endometrial cancer in a Polish subpopulation. Journal of Obstetrics and Gynaecology 36 311-317. (doi:10.1111/j.1447-0756.2009.01143.x)
46. Spurdle AB, Thompson DJ, Ahmed S, Ferguson K, Healey CS, O'Mara T, Walker LC, Montgomery SB, Dermitzakis ET, Australian National Endometrial Cancer Study Group et al. 2011 Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nature Genetics 43 451-454. (doi:10.1038/ng.812)
47. Sur I, Neumann S & Noegel AA 2014 Nesprin-1 role in DNA damage response. Nucleus 5 173-191. (doi:10.4161/nucl.29023)
48. TessemaM,Willink R,Do K, Yu YY, YuW,MachidaEO, Brock M, VanNeste L, Stidley CA, Baylin SB et al. 2008 Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. Cancer Research 68 1707-1714. (doi:10.1158/0008-5472.CAN-07-6325)
49. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, MaranianM, Seal S, Ghoussaini M, Hines S, Healey CS et al. 2010 Genome-wide association study identifies five new breast cancer susceptibility loci. Nature Genetics 42 504-507. (doi:10.1038/ng.586)
50. Ward LD & Kellis M 2012 HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Research 40 D930-D934. (doi:10.1093/nar/gkr917)
51. Wedren S, Lovmar L, Humphreys K, Magnusson C, Melhus H, Syvanen AC, Kindmark A, Landegren U, Fermer ML, Stiger F et al. 2008 Estrogen receptor a gene polymorphism and endometrial cancer risk - a case-control study. BMC Cancer 8 322. (doi:10.1186/1471-2407-8-322)
52. Weiderpass E, Persson I,Melhus H, Wedren S, Kindmark A & Baron JA 2000 Estrogen receptor a gene polymorphisms and endometrial cancer risk. Carcinogenesis 21 623-627. (doi:10.1093/carcin/21.4.623)
53. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI & Young RA 2013 Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153 307-319. (doi:10.1016/j.cell.2013.03.035)
54. Zhang Q, Skepper JN, Yang F, Davies JD, Hegyi L, Roberts RG, Weissberg PL, Ellis JA & Shanahan CM 2001 Nesprins: a novel family of spectrinrepeat-containing proteins that localize to the nuclear membrane in multiple tissues. Journal of Cell Science 114 4485-4498.
55. ZhengW,Long J,GaoYT, LiC,ZhengY, XiangYB,WenW, Levy S,Deming SL, Haines JL et al. 2009 Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nature Genetics 41 324-328. (doi:10.1038/ng.318)